Back to SYRE
FMR LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
39
Latest value
$51.3M
Q3 2026
Peak value
$809.9M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $50.3M |
| Q4 2023 | $29.4M |
| Q1 2024 | $184.8M |
| Q1 2024 | $52M |
| Q1 2024 | $7.5M |
| Q1 2024 | $2.2M |
| Q2 2024 | $129.1M |
| Q2 2024 | $32.9M |
| Q2 2024 | $11.1M |
| Q2 2024 | $3.4M |
| Q3 2024 | $163.1M |
| Q3 2024 | $41.4M |
| Q3 2024 | $14.6M |
| Q3 2024 | $5.1M |
| Q4 2024 | $142.3M |
| Q4 2024 | $44M |
| Q4 2024 | $14.7M |
| Q4 2024 | $4M |
| Q1 2025 | $99.8M |
| Q1 2025 | $33.1M |
| Q1 2025 | $10.2M |
| Q1 2025 | $2.8M |
| Q3 2025 | $110.4M |
| Q3 2025 | $40M |
| Q3 2025 | $1.5M |
| Q4 2025 | $274.1M |
| Q4 2025 | $103.7M |
| Q4 2025 | $3.5M |
| Q1 2026 | $430.1M |
| Q1 2026 | $160.3M |
| Q1 2026 | $3.8M |
| Q2 2026 | $809.9M |
| Q2 2026 | $336.7M |
| Q2 2026 | $6.8M |
| Q2 2026 | $3.1M |
| Q3 2026 | $795.4M |
| Q3 2026 | $348.1M |
| Q3 2026 | $6.8M |
| Q3 2026 | $51.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $51.3M | 575.7K | — | — |
| Q3 2026 | $6.8M | 76.2K | — | — |
| Q3 2026 | $348.1M | 3.91M | — | — |
| Q3 2026 | $795.4M | 8.93M | — | — |
| Q2 2026 | $3.1M | 34.9K | — | — |
| Q2 2026 | $6.8M | 76.2K | — | — |
| Q2 2026 | $336.7M | 3.79M | — | — |
| Q2 2026 | $809.9M | 9.12M | — | — |
| Q1 2026 | $3.8M | 76.2K | — | — |
| Q1 2026 | $160.3M | 3.18M | — | — |
| Q1 2026 | $430.1M | 8.53M | — | — |
| Q4 2025 | $3.5M | 107.5K | — | — |
| Q4 2025 | $103.7M | 3.17M | — | — |
| Q4 2025 | $274.1M | 8.37M | — | — |
| Q3 2025 | $1.5M | 87.5K | — | — |
| Q3 2025 | $40M | 2.39M | — | — |
| Q3 2025 | $110.4M | 6.59M | — | — |
| Q1 2025 | $2.8M | 171.2K | — | — |
| Q1 2025 | $10.2M | 631.5K | — | — |
| Q1 2025 | $33.1M | 2.05M | — | — |
| Q1 2025 | $99.8M | 6.18M | — | — |
| Q4 2024 | $4M | 171.1K | — | — |
| Q4 2024 | $14.7M | 630.2K | — | — |
| Q4 2024 | $44M | 1.89M | — | — |
| Q4 2024 | $142.3M | 6.11M | — | — |
| Q3 2024 | $5.1M | 172.4K | — | — |
| Q3 2024 | $14.6M | 497.6K | — | — |
| Q3 2024 | $41.4M | 1.41M | — | — |
| Q3 2024 | $163.1M | 5.55M | — | — |
| Q2 2024 | $3.4M | 143.8K | — | — |
| Q2 2024 | $11.1M | 472.6K | — | — |
| Q2 2024 | $32.9M | 1.40M | — | — |
| Q2 2024 | $129.1M | 5.49M | — | — |
| Q1 2024 | $2.2M | 58.1K | — | — |
| Q1 2024 | $7.5M | 197.9K | — | — |
| Q1 2024 | $52M | 1.39M | — | — |
| Q1 2024 | $184.8M | 4.93M | — | — |
| Q4 2023 | $29.4M | 1.39M | — | — |
| Q4 2023 | $50.3M | 2.40M | — | — |
Other funds holding SYRE
$383.5M
$377.5M
$328.7M
$318.8M